Fresenius Kabi USA, LLC LVP software of the Ivenix Infusion System recall: Potential software anomaly that can cause the pump to report a false
Potential software anomaly that can cause the pump to report a false battery-health value (typically 69%) and trigger a battery-depletion alarm that will shut down the pump unless it is reconnected to AC mains power.
The hazard
Potential software anomaly that can cause the pump to report a false battery-health value (typically 69%) and trigger a battery-depletion alarm that will shut down the pump unless it is reconnected to AC mains power.
Recall details
- Recall number
- Z-2223-2026
- Published
- June 10, 2026
- Risk level
- Class I
- Status
- Ongoing
- Issued by
- U.S. Food and Drug Administration
- Brand
- Fresenius Kabi USA, LLC
- Product type
- Medical devices
- Units affected
- 32 systems
- Distribution
- Nationwide
- Made in
- United States
- Lot / code info
- Product Code LVP-SW-0005. UDI-DI: 00811505030122. Software Version 5.10.2
Products covered by this recall
LVP software of the Ivenix Infusion System (IIS); Product Code LVP-SW-0005.
What this device recall means for you
Most device recalls are corrections rather than removals: the product stays in use and the manufacturer issues updated instructions, a software patch or a replacement part. Check which applies before you change anything.
- Match the model, catalogue and lot numbers above against the label on your device or its packaging.
- If the device is implanted or you depend on it daily, do not remove, disable or stop using it before speaking to your clinician. The notice above explains the specific failure mode they need to know about.
- If you are a clinician or facility, quarantine affected stock, check whether the manufacturer has issued a field correction, and work through your usual recall log.
- Home users should contact the supplier who provided the device — a hospital, DME company or online retailer — as they hold the serial-number records needed to action the recall.
- Problems with a device can be reported to the FDA through MedWatch, which feeds the same enforcement database this page is built from.
Replacements, repairs and reimbursement
Device remedies are handled through the supply chain, so the route depends on who sold you the unit.
- Contact the distributor or clinic named on your paperwork and quote the recall number shown on this page. They will tell you whether the remedy is a repair, a replacement or an instruction update.
- Consumer-purchased devices such as monitors and test kits are normally replaced free of charge by the manufacturer, who pays return shipping.
- If the device was billed to insurance or Medicare, the replacement is usually billed the same way; you should not be charged a second deductible for a recall.
- Keep every piece of correspondence. If a recalled device caused harm, that paper trail is what a claim will rest on.
Company contact: Fresenius Kabi USA, LLC — 50 High St Ste 50, North Andover, MA, 01845-2620
The official notice
This page summarises a notice published by U.S. Food and Drug Administration. The agency notice is the authoritative version — read it before you act, and treat it as the final word if anything here looks different.
Open the FDA — Device enforcement record U.S. Food and Drug Administration recalls
Related recalls
-
Class I · last month
Fresenius Kabi USA, LLC Tyenne Injection, 400 mg/20 mL , 20 mL vial recall: Presence of particulate matter:An internal investigation at the firm found
Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles.
-
Class I · 2 months ago
Fresenius Kabi USA, LLC Morphine Sulfate Injection, USP, 2 mg /mL recall: Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL
Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL.
-
Class II · 3 months ago
Fresenius Kabi USA, LLC Naropin , 0.5%, 100 mg per 20 mL , Twenty-five recall: Presence of Particulate Matter: Hair was found in products
Presence of Particulate Matter: Hair was found in products
-
Class II · 3 months ago
Fresenius Kabi USA, LLC Xylocaine , 1%, 200 mg per 20 mL , 25 Multiple-Dose Vials recall: Presence of Particulate Matter: Hair was found in products
Presence of Particulate Matter: Hair was found in products
-
Class II · 3 months ago
Fresenius Kabi USA, LLC Lidocaine HCl Injection, USP, 2%, 100 mg per 5 mL recall: Presence of Particulate Matter: Hair was found in products
Presence of Particulate Matter: Hair was found in products
-
Class II · 3 months ago
Fresenius Kabi USA, LLC Xylocaine , 1%, 500 mg per 50 mL , 25 Multiple-Dose Vials recall: Presence of Particulate Matter: Hair was found in products
Presence of Particulate Matter: Hair was found in products